These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 15616206)

  • 21. [HLA-incompatibility and kidney transplant: a question of desensitization].
    Grosjean F
    G Ital Nefrol; 2011; 28(6):581. PubMed ID: 22167608
    [No Abstract]   [Full Text] [Related]  

  • 22. [Research in transplant immunology in kidney transplantation].
    Tan JM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):649-50. PubMed ID: 15932722
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of antibody-mediated rejection after kidney transplantation.
    Sureshkumar KK; Oti IU; Baroody SC; Hussain SM; Carpenter BJ; Nghiem DD; Marcus RJ
    Transplant Proc; 2008 Jun; 40(5):1373-4. PubMed ID: 18589109
    [No Abstract]   [Full Text] [Related]  

  • 24. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 25. [Future problems for the further improvement of long renal graft survival].
    Morozumi K; Takeda A; Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(5):508-16. PubMed ID: 16130405
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
    Norman DJ; Bennett WM; Cobanoglu A; Hershberger R; Hosenpud JD; Meyer MM; Misiti J; Ott G; Ratkovec R; Shihab F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):802-3. PubMed ID: 8438490
    [No Abstract]   [Full Text] [Related]  

  • 27. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
    Kriaa F; Hiesse C; Alard P; Lantz O; Noury J; Charpentier B; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):817-9. PubMed ID: 8438496
    [No Abstract]   [Full Text] [Related]  

  • 28. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
    Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
    Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunosuppression in the kidney transplant. Old drugs and new acquisitions].
    Rodríguez Ferrero M; Valderrábano F
    Rev Clin Esp; 1997 Oct; 197(10):703-12. PubMed ID: 9424669
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal antibodies in organ transplantation.
    Valdés RH
    Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
    [No Abstract]   [Full Text] [Related]  

  • 31. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
    Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of ABO-incompatible kidney transplantation in children.
    Shishido S; Hasegawa A
    Pediatr Transplant; 2005 Apr; 9(2):148-54. PubMed ID: 15787785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunosuppression after organ transplantation].
    Wagner K; Erhard J
    Zentralbl Chir; 1992; 117(12):648-52. PubMed ID: 1285470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
    Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
    Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
    [No Abstract]   [Full Text] [Related]  

  • 35. Locoregional immunosuppression of organ transplants.
    Gruber SA
    Immunol Rev; 1992 Oct; 129():5-30. PubMed ID: 1464421
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal transplant and chronic rejection in pediatrics].
    Cano FJ
    Rev Med Chil; 1998 Jan; 126(1):96-106. PubMed ID: 9629760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of an anti-LFA-1 antibody in renal allograft rejection in sheep.
    Grooby WL; Carter JK; Rao MM; Dewan P; Seymour AE; Brandon M; Russ GR
    Transplant Proc; 1992 Oct; 24(5):2304. PubMed ID: 1413070
    [No Abstract]   [Full Text] [Related]  

  • 38. Zenapax: transplant's first humanized monoclonal antibody.
    Bell J; Colaneri J
    ANNA J; 1998 Aug; 25(4):429-30. PubMed ID: 9791317
    [No Abstract]   [Full Text] [Related]  

  • 39. Rejection of the kidney allograft.
    Nankivell BJ; Alexander SI
    N Engl J Med; 2010 Oct; 363(15):1451-62. PubMed ID: 20925547
    [No Abstract]   [Full Text] [Related]  

  • 40. New immunosuppressive protocols with the advent of novel biological drugs.
    Cruzado JM; Bestard O; Grinyó JM
    Transplantation; 2009 Aug; 88(3 Suppl):S20-3. PubMed ID: 19667957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.